|
Table 5: values of the complete blood count parameters for men according to provinces |
||||||||||||||
|
Males |
P value
|
|||||||||||||
|
Disctrict |
Tangier-Tetouan (n=3334) |
Tetouan (n=1942) |
Mdiq-Fnideq (n=1319) |
Chefchaouen (n=1335) |
||||||||||
|
Hematological parameters |
|
Reference interval |
|
Reference interval |
|
Reference interval |
|
Reference interval |
||||||
|
Mean (SD) |
Median |
2.5-97.5 Percentile |
Mean (SD) |
Median |
2.5-97.5 Percentile |
Mean (SD) |
Median |
2.5-97.5 Percentile |
Mean (SD) |
Median |
2.5-97.5 Percentile |
|||
|
RBCx1012/L |
5.13 (0.39) |
5.11 |
4.39-5.95 |
5.10 (0.40) |
5.09 |
4.33-5.92 |
5.08 (0.37) |
5.07 |
4.37-5.84 |
5.15 (0.42) |
5.12 |
4.4-6.1 |
<0.001 a |
|
|
HGB (g/dL) |
15.02 (1.05) |
15 |
12.9-17 |
14.97 (1.06) |
15 |
13-17.1 |
14.93 (0.99) |
14.9 |
13.1-16.9 |
15.13 (1.06) |
15.1 |
13.2-17.5 |
<0.001 a |
|
|
HCT (%) |
44.13 (2.93) |
44.2 |
38.5-50 |
43.89 (3.20) |
44 |
38.1-49.5 |
43.81 (2.86) |
43.8 |
38.2-49.4 |
44.43 (3.20) |
44.2 |
38.6-51 |
<0.001 a |
|
|
MCV (fL) |
86.20 (4.52) |
86.5 |
77.0-94.4 |
86.27 (4.44) |
86.5 |
77.5-94.4 |
86.34 (3.87) |
86.4 |
78.1-93.6 |
86.34 (4.27) |
86.5 |
77.3-94.2 |
0.949 b |
|
|
MCH (pg) |
29.34 (1.90) |
29.6 |
24.9-32.3 |
29.45 (1.87) |
29.6 |
25.3-32.5 |
29.41 (1.65) |
29.6 |
26-32.3 |
29.45 (1.84) |
29.6 |
25.3-32.3 |
0.428 b |
|
|
MCHC (g/dL) |
34.02 (1.14) |
34.1 |
31.5-36 |
34.11 (1.08) |
34.2 |
32-36.2 |
34.08 (1.09) |
34.1 |
31.9-36.1 |
34.06 (1.13) |
34.1 |
31.7-36 |
0.244 b |
|
|
WBCx109 /L |
6.98 (1.68) |
6.8 |
4.1-10.8 |
7.11 (1.76) |
7 |
3.9-11 |
7.10 (1.69) |
7 |
4.2-10.7 |
7.04 (1.78) |
6.8 |
4.1-11 |
0.020 a |
|
|
LYMx109/L |
2.28 (0.64) |
2.2 |
1.2-3.7 |
2.36 (0.67) |
2.3 |
1.2-3.9 |
2.34 (0.67) |
2.2 |
1.3-3.8 |
2.35 (0.67) |
2.3 |
1.3-3.8 |
<0.001 a |
|
|
MONx109 /L |
0.65 (0.30) |
0.6 |
0.2-1.2 |
0.66 (0.31) |
0.6 |
0.2-1.2 |
0.67 (0.31) |
0.7 |
0.2-1.2 |
0.68 (0.31) |
0.7 |
0.2-1.2 |
0.002 a |
|
|
NEUx109/L |
3.94 (1.31) |
3.8 |
1.8-7 |
3.97 (1.34) |
3.8 |
1.7-6.9 |
3.99 (1.31) |
3.8 |
1,8-7 |
3.93 (1.37) |
3.8 |
1.7-6.96 |
0.486 b |
|
|
EOSx109/L |
0.12 (0.18) |
0 |
0-0.6 |
0.13 (0.16) |
0.09 |
0-0.5 |
0.11 (0.17) |
0 |
0-0.6 |
0.12 (0.18) |
0 |
0-0.6 |
<0.001 a |
|
|
BASx109/L |
0.007 (0.02) |
0 |
0-0.08 |
0.005 (0.02) |
0 |
0-0.08 |
0.004 (0.02) |
0 |
0-0.08 |
0.006 (0.02) |
0 |
0-0.08 |
<0.001 a |
|
|
PLTx109/L |
223.62 (51.74) |
218 |
145-339 |
223.96 (52.5) |
218 |
145-351 |
222.78 (50.04) |
218 |
147-337 |
220.58 (49.73) |
217 |
146-331 |
0.492 b |
|
|
MPV (fL) |
11.47 (1.09) |
11.4 |
9.4-13.7 |
11.46 (1.11) |
11.4 |
9.4-13.7 |
11.44 (1.13) |
11.4 |
9.3-13.7 |
11.60 (1.09) |
11.6 |
9.5-13.8 |
<0.001 a |
|
|
SD, standard deviation; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; WBC, white blood cell; LYM, lymphocytes; MON, monocytes; NEU, neutrophils; EOS, eosinophils; BAS, basophils; PLT, platelets; MPV, mean platelet volume. Statistical comparison: Chi squared test and Kruskal-Wallis test for nonnormally distributed parameters was done between the four age groups with the Bonferroni method adjustment of p value. p<0.05 was considered as statistically significant. a statistically significant. b statistically non-significant. |
||||||||||||||